SCHEMBL7562736

SCHEMBL7562736

COc1ccccc1COCCCOc1ccc([C@H]2[C@@H](OCc3ccc4ccccc4c3)CNC[C@H]2OCc2ccc3ccccc3c2)cc1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6041783 1.00 REN (0.80) REN
SCHEMBL6041998 0.89 REN (1.00) REN
SCHEMBL7379865 0.88 REN (0.83) REN
SCHEMBL7545740 0.87 REN (0.82) REN
SCHEMBL13486098 0.87 REN (0.82) REN
SCHEMBL14190816 0.87 REN (0.82) REN
SCHEMBL17812896 0.87 REN (0.82) REN
SCHEMBL799679 0.87 REN (0.82) REN
SCHEMBL20000697 0.87 REN (0.82) REN
SCHEMBL1942133 0.87 REN (0.73) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed
US-6150526-A Piperidine derivative having renin inhibiting activity HOFFMANN-LA ROCHE INC. (US) 2000-11-21 US disclosed
US-6051712-A PREVENTION OF HIGH BLOOD PRESSURE AND CARDIAC INSUFFICIENCY, AS WELL AS GLAUCOMA, CARDIAC INFARCT, KIDNEY INSUFFICIENCY AND RESTENOSIS HOFFMANN-LA ROCHE INC. (US) 2000-04-18 US disclosed